These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 20079471)

  • 41. Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.
    Karam M; Bièche I; Legay C; Vacher S; Auclair C; Ricort JM
    J Cell Mol Med; 2014 Dec; 18(12):2536-52. PubMed ID: 25287328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen regulation of anti-apoptotic Bcl-2 family member Mcl-1 expression in breast cancer cells.
    Schacter JL; Henson ES; Gibson SB
    PLoS One; 2014; 9(6):e100364. PubMed ID: 24971890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
    Thaler S; Schmidt M; Schad A; Sleeman JP
    Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
    Fritah A; Redeuilh G; Sabbah M
    J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
    J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
    Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
    Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New stably transfected bioluminescent cells expressing FLAG epitope-tagged estrogen receptors to study their chromatin recruitment.
    Badia E; Escande A; Balaguer P; Métivier R; Cavailles V
    BMC Biotechnol; 2009 Sep; 9():77. PubMed ID: 19737428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zinc finger nuclease-mediated knockout of AHR or ARNT in human breast cancer cells abolishes basal and ligand-dependent regulation of CYP1B1 and differentially affects estrogen receptor α transactivation.
    Ahmed S; Wang A; Celius T; Matthews J
    Toxicol Sci; 2014 Mar; 138(1):89-103. PubMed ID: 24299737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estradiol regulates Tumor Necrosis Factor-α expression and secretion in Estrogen Receptor positive breast cancer cells.
    To SQ; Cheung V; Lazarus KA; Knower KC; Clyne CD
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):21-8. PubMed ID: 25004254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
    J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
    Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
    Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
    Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells.
    Ying S; Dünnebier T; Si J; Hamann U
    PLoS One; 2013; 8(9):e75695. PubMed ID: 24086615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GC-rich promoter elements maximally confers estrogen-induced transactivation of LRP16 gene through ERalpha/Sp1 interaction in MCF-7 cells.
    Han WD; Si YL; Zhao YL; Li Q; Wu ZQ; Hao HJ; Song HJ
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):47-56. PubMed ID: 18206366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
    Matthews J; Wihlén B; Thomsen J; Gustafsson JA
    Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.
    Grober OM; Mutarelli M; Giurato G; Ravo M; Cicatiello L; De Filippo MR; Ferraro L; Nassa G; Papa MF; Paris O; Tarallo R; Luo S; Schroth GP; Benes V; Weisz A
    BMC Genomics; 2011 Jan; 12():36. PubMed ID: 21235772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.
    Schultz DJ; Wickramasinghe NS; Ivanova MM; Isaacs SM; Dougherty SM; Imbert-Fernandez Y; Cunningham AR; Chen C; Klinge CM
    Mol Cancer Ther; 2010 Mar; 9(3):594-605. PubMed ID: 20197399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
    Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
    Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
    Mishra AK; Abrahamsson A; Dabrosin C
    Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.